People with type 2 diabetes who take Wegovy may have an increased risk of plaque buildup in their arteries, leading to dangerous blood clots, and should be carefully monitored

A structured monitoring plan typically includes: Baseline labs : HbA1c, fasting glucose, kidney function, and lipid profile before starting Gradual dose escalation : starting at the lowest dose for 4 weeks and increasing only if tolerated, to minimise nausea Follow-up HbA1c : usually at 12 weeks to confirm the medication is working as expected Weight and waist circumference tracking : alongside diet and activity counselling, since medication alone rarely sustains results without lifestyle support Screening for rare but serious side effects , including pancreatitis symptoms and gallbladder issues, especially in the first few months what happens if you stop treatment : check full details Patients on continuous glucose monitoring often see the clearest, fastest feedback on how their body responds to either option one more reason a supervised program beats a self-directed one

Practice Areas Partner Ron Parry Ron Parry is a seasoned trial attorney with decades of litigation experience representing clients in high-stakes class actions, complex commercial disputes, and personal injury matters
Companys may hire a third-party laboratory to perform sampling and testing that demonstrates the shipment is compliant with regulations